Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

Literature DB >> 34447992

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

Theresa A McDonagh, Marco Metra, Marianna Adamo, Roy S Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel, John G F Cleland, Andrew J S Coats, Maria G Crespo-Leiro, Dimitrios Farmakis, Martine Gilard, Stephane Heymans, Arno W Hoes, Tiny Jaarsma, Ewa A Jankowska, Mitja Lainscak, Carolyn S P Lam, Alexander R Lyon, John J V McMurray, Alexandre Mebazaa, Richard Mindham, Claudio Muneretto, Massimo Francesco Piepoli, Susanna Price, Giuseppe M C Rosano, Frank Ruschitzka, Anne Kathrine Skibelund.

Abstract

Entities: Chemical

Keywords: advanced heart failure; transplantation; Guidelines; acute heart failure; arrhythmias; cardiac resynchronization therapy; comorbidities; diagnosis; ejection fraction; heart failure; hospitalization; mechanical circulatory support; multidisciplinary management; natriuretic peptides; neuro-hormonal antagonists; pharmacotherapy

Mesh：

Year: 2021 PMID： 34447992 DOI： 10.1093/eurheartj/ehab368

Source DB: PubMed Journal: Eur Heart J ISSN： 0195-668X Impact factor: 29.983

Keyword Cloud
Cited

× No keyword cloud information.

819 in total

Review 1. Comparisons of pleiotropic effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction.

Authors: Belma Turan; Aysegul Durak; Yusuf Olgar; Erkan Tuncay
Journal: Mol Cell Biochem Date: 2022-05-22 Impact factor: 3.396

2. Non-cardiovascular medication and readmission for heart failure: an observational cohort study.

Authors: Willemien J Kruik-Kollöffel; Enriqueta Vallejo-Yagüe; Kris L L Movig; Gerard C M Linssen; Edith M Heintjes; Job van der Palen
Journal: Int J Clin Pharm Date: 2022-05-28

Review 3. NLRP3 Inflammasome: a Novel Insight into Heart Failure.

Authors: Yunjiao Wang; Yanyang Li; Wanqin Zhang; Zhuo Yuan; Shichao Lv; Junping Zhang
Journal: J Cardiovasc Transl Res Date: 2022-06-13 Impact factor: 4.132

Review 4. Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction.

Authors: Michele Correale; Pietro Mazzeo; Lucia Tricarico; Francesca Croella; Martino Fortunato; Michele Magnesa; Marco Amatruda; Simona Alfieri; Salvatore Ferrara; Vincenzo Ceci; Giuseppe Dattilo; Marco Mele; Massimo Iacoviello; Natale Daniele Brunetti
Journal: Clin Drug Investig Date: 2022-06-20 Impact factor: 2.859

Review 5. Therapeutic Approaches in Heart Failure with Preserved Ejection Fraction (HFpEF) in Children: Present and Future.

Authors: Bibhuti B Das
Journal: Paediatr Drugs Date: 2022-05-02 Impact factor: 3.022

6. Lack of correlation between different congestion markers in acute decompensated heart failure.

Authors: Svenja Haag; Alexander Jobs; Thomas Stiermaier; Carlo-Federico Fichera; Christina Paitazoglou; Ingo Eitel; Steffen Desch; Holger Thiele
Journal: Clin Res Cardiol Date: 2022-06-01 Impact factor: 5.460

Review 7. Thyroid disorders and cardiovascular manifestations: an update.

Authors: Stavroula A Paschou; Evanthia Bletsa; Panagiota K Stampouloglou; Vasiliki Tsigkou; Angeliki Valatsou; Katerina Stefanaki; Paraskevi Kazakou; Michael Spartalis; Eleftherios Spartalis; Evangelos Oikonomou; Gerasimos Siasos
Journal: Endocrine Date: 2022-01-15 Impact factor: 3.633